{{chembox
| verifiedrevid = 384239649
| Reference =<ref>[http://www.sigmaaldrich.com/catalog/ProductDetail.do?lang=en&N4=482609|ALDRICH&N5=SEARCH_CONCAT_PNO|BRAND_KEY&F=SPEC N-((2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl)-L-leucine] at [[Sigma-Aldrich]]</ref>
| ImageFile =Ubenimex2DCSD.svg
| ImageSize =250px
| ImageFile2 = Ubenimex3DanJ.gif
| ImageSize2 = 250px
| IUPACName = (2''S'')-2-<nowiki>[[</nowiki>(2''S'',3''R'')-3-Amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid
| OtherNames =Bestatin; ''N''-[(2''S'',3''R'')-3-Amino-2-hydroxy-4-phenylbutyryl]-<small>L</small>-leucine
|Section1={{Chembox Identifiers
| CASNo = 58970-76-6
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 29292
| CASNo1 = 65391-42-6 
| CASNo1_Comment = ([[hydrochloride|HCl]])
| PubChem =72172
| SMILES =CC(C)C[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](CC1=CC=CC=C1)N)O
| ChemSpiderID = 65145
| InChI = 1/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1
| InChIKey = VGGGPCQERPFHOB-RDBSUJKOBZ
| StdInChI = 1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1
| StdInChIKey = VGGGPCQERPFHOB-RDBSUJKOSA-N
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = I0J33N5627
  }}
|Section2={{Chembox Properties
| C =16|H=24|N=2|O=4
| Appearance =
| Density =
| MeltingPtC = 245
| MeltingPt_notes = (decomposes)
| BoilingPt =
| Solubility =
  }}
|Section3={{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt = 
| SPhrases = {{S22}} {{S24/25}}
  }}
}}

'''Ubenimex''' ([[International Nonproprietary Name|INN]]), also known more commonly as '''bestatin''', is a competitive, reversible [[Protease inhibitor (pharmacology)|protease inhibitor]]. It is an [[enzyme inhibitor|inhibitor]] of [[arginyl aminopeptidase]] (aminopeptidase B),<ref>{{cite journal | year = 1976 | issue = 29 | pages = 97–99 | title = Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes.| author = Umezawa, H.| author2 = Aoyagi, T.| author3 = Suda, H.| author4 = Hamada, M.| author5 = Takeuchi, T.}}</ref> [[leukotriene A4 hydrolase|leukotriene A<sub>4</sub> hydrolase]] (a [[zinc metalloprotease]] that displays both [[epoxide hydrolase]] and [[aminopeptidase]] activities),<ref>{{cite journal | year = 1994 | issue = 48 | pages = 131–137 | title = Modulation of pulmonary leukotriene formation and perfusion pressure by Bestatin, an inhibitor of leukotriene A4 hydrolase.| author = Muskardin, D.T.| author2 = Voelkel, N.F.| author3 = Fitzpatrick, F.A.}}</ref> [[alanyl aminopeptidase]] (aminopeptidase M/N),<ref>{{cite journal | year = 1999 | issue = 5 | pages = 729–734 | title = Induction of apoptosis by Bestatin (ubenimex) in human leukemic cell lines |author1=K Sekine |author2=H Fujii |author3=F Abe | volume = 13}}</ref> [[leucyl/cystinyl aminopeptidase]] (oxytocinase/vasopressinase),<ref name="pmid10985965">{{cite journal | vauthors = Nakanishi Y, Nomura S, Okada M, Ito T, Katsumata Y, Kikkawa F, Hattori A, Tsujimoto M, Mizutani S | title = Immunoaffinity purification and characterization of native placental leucine aminopeptidase/oxytocinase from human placenta | journal = Placenta | volume = 21 | issue = 7 | pages = 628–34 | year = 2000 | pmid = 10985965 | doi = 10.1053/plac.2000.0564 | url = }}</ref><ref name="pmid8801531">{{cite journal | vauthors = Naruki M, Mizutani S, Goto K, Tsujimoto M, Nakazato H, Itakura A, Mizuno K, Kurauchi O, Kikkawa F, Tomoda Y | title = Oxytocin is hydrolyzed by an enzyme in human placenta that is identical to the oxytocinase of pregnancy serum | journal = Peptides | volume = 17 | issue = 2 | pages = 257–61 | year = 1996 | pmid = 8801531 | doi = 10.1016/0196-9781(95)02124-8| url = }}</ref> and [[membrane dipeptidase]] (leukotriene D<sub>4</sub> hydrolase). It is being studied for use in the treatment of [[acute myelocytic leukemia]]<ref>{{Cite journal | pmid = 12938265 | year = 2003 | last1 = Hirayama | first1 = Y | last2 = Sakamaki | first2 = S | last3 = Takayanagi | first3 = N | last4 = Tsuji | first4 = Y | last5 = Sagawa | first5 = T | last6 = Chiba | first6 = H | last7 = Matsunaga | first7 = T | last8 = Niitsu | first8 = Y | title = Chemotherapy with ubenimex corresponding to patient age and organ disorder for 18 cases of acute myelogeneous leukemia in elderly patients--effects, complications and long-term survival | volume = 30 | issue = 8 | pages = 1113–8 | journal = Gan to kagaku ryoho. Cancer & chemotherapy}}</ref> and [[lymphedema]]<ref>{{Cite journal | pmid = 28490670 | year = 2017 | last1 = Tian | first1 = W | last2 = Rockson | first2 = S | last3 = Jiang | first3 = X | last4 = Kim | first4 = J | last5 = Begaye | first5 = A | last6 = Shuffle | first6 = EM | last7 = Tu | first7 = AB | last8 = Cribb | first8 = M | last9 = Nepiyushchikh | first9 = Z | last10 = Feroze | first10 = AH | last11 = Zamanian | first11 = RT | last12 = Dhillon | first12 = RT | last13 = Voelkel | first13 = NF | last14 = Peters-Golden | first14 = M | last15 = Kitajewski | first15 = J | last16 = Dixon | first16 = JB | last17 = Nicolls | first17 = MR | title = Leukotriene B4 antagonism ameliorates experimental lymphedema | volume = 9 | issue = 389 | pages = eaal3920 | journal = Science Translational Medicine}}</ref>.
It is derived from ''[[Streptomyces olivoreticuli]]''.<ref>{{cite journal|last=Bauvois|first=B|author2=Dauzonne, D |title=Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospects|journal=Medicinal Research Reviews|volume=26|issue=1|pages=88–130|doi=10.1002/med.20044|pmid=16216010|date=January 2006}}</ref> Ubenimex has been found to inhibit the enzymatic degradation of [[oxytocin]], [[vasopressin]], [[enkephalin]]s, and various other [[peptide]]s and compounds.{{Citation needed|date=October 2015}}

[[Image:Bestatin.jpg|thumb|350px|left|upright=2.0|alt=Crystal structure of ubenimex|Crystal structure of ubenimex in the binding pocket of leukotriene A4 hydrolase. Rendered from PDB [http://www.rcsb.org/pdb/explore/explore.do?structureId=1HS6 1HS6].]]
{{clear left}}

==See also==
* [[Amastatin]]
* [[Pepstatin]]

==References==
{{Reflist|2}}

==External links==
* The [[MEROPS]] online database for peptidases and their inhibitors: [http://merops.sanger.ac.uk/cgi-bin/smi_summary?mid=J00014 Bestatin]


{{Leukotrienergics}}
{{Peptide receptor modulators}}
{{Opioidergics}}

[[Category:Enkephalinase inhibitors]]
[[Category:Protease inhibitors]]
[[Category:Experimental cancer drugs]]


{{pharma-stub}}